Author Correction: An intranasal vaccine comprising SARS‑CoV‑2 spike receptor‑binding domain protein entrapped in mannose‑conjugated chitosan nanoparticle provides protection in hamsters
Main Authors: | Kairat Tabynov, Maxim Solomadin, Nurkeldi Turebekov, Meruert Babayeva, Gleb Fomin, Ganesh Yadagiri, Sankar Renu, Toktassyn Yerubayev, Nikolai Petrovsky, Gourapura J. Renukaradhya, Kaissar Tabynov |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-39818-8 |
Similar Items
-
An intranasal vaccine comprising SARS-CoV-2 spike receptor-binding domain protein entrapped in mannose-conjugated chitosan nanoparticle provides protection in hamsters
by: Kairat Tabynov, et al.
Published: (2023-07-01) -
An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission
by: Kairat Tabynov, et al.
Published: (2022-02-01) -
A recombinant Artemisia vulgaris pollen adjuvanted Art v 1 protein-based vaccine treats allergic rhinitis and bronchial asthma using pre- and co-seasonal ultrashort immunotherapy regimens in sensitized mice
by: Meruert Babayeva, et al.
Published: (2022-11-01) -
Evaluation of a Novel Adjuvanted Vaccine for Ultrashort Regimen Therapy of Artemisia Pollen-Induced Allergic Bronchial Asthma in a Mouse Model
by: Kairat Tabynov, et al.
Published: (2022-03-01) -
A Spike Protein-Based Subunit SARS-CoV-2 Vaccine for Pets: Safety, Immunogenicity, and Protective Efficacy in Juvenile Cats
by: Kairat Tabynov, et al.
Published: (2022-03-01)